Glucosamine and warfarin alert
Glucosamine is widely used for the symptoms of osteoarthritis. Recent reports have suggested that it may interact with warfarin and thus make blood less likely to clot. The mechanism for this is uncertain. However, Arthritis Australia recommends that patients on warfarin who are starting or stopping glucosamine should have their INR (blood clotting) checked regularly for the first month. Patients who are on stable doses of both are unlikely to have problems.
Prof. Graeme Jones
Arthritis Australia Medical Director
Discover more...
-
Landmark Research Mission gives hope to 7 million Australians living with the pain of arthritis and musculoskeletal conditions
Media Release Arthritis Australia has welcomed the Albanese Government’s announcement today of a dedicated Medical Research Future Fund (MRFF) Mission of $100 million for Arthritis...
-
Building the Case for a National Arthritis & Musculoskeletal Research Mission
On March 30 we launched our new report, Evaluation of Preferred Investment Models for Arthritis and Musculoskeletal Research, making a powerful case for a dedicated...
-
Arthritis Australia appoints Chief Executive Officer
MEDIA RELEASE – FOR IMMEDIATE RELEASE3 February 2026 Arthritis Australia today announced the appointment of Louise Hardy as Chief Executive Officer, following her tenure as...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
